Company also raises $43.75 million in its IPO at same price per share
By Devika Patel
Knoxville, Tenn., Oct. 6 – Mirna Therapeutics, Inc. completed a $16.77 million private placement of stock with the Cancer Prevention and Research Institute of Texas on Oct. 5, according to an 8-K filed Wednesday with the Securities and Exchange Commission. The company also raised $43.75 million in its initial public offering at the same price per share on Oct. 6.
In the placement, the company sold 2,395,010 common shares at $7.00 apiece. The price per share represents a 0.57% discount to $7.04, the Oct. 2 closing share price.
The deal was conducted alongside a previously announced $43.75 million initial public sale of 6.25 million shares at $7.00 per share that priced on Oct. 1. The public offering was conducted by bookrunners Citigroup Global Markets Inc. and Leerink Partners LLC and has a greenshoe of $6,562,500, or 937,500 shares, which is yet to be exercised.
Mirna is a clinical-stage biopharmaceutical company based in Austin, Texas.
| Issuer: | Mirna Therapeutics, Inc.
|
| Issue: | Common shares
|
| Amount: | $16,765,070
|
| Shares: | 2,395,010
|
| Price: | $7.00
|
| Warrants: | No
|
| Investor: | Cancer Prevention and Research Institute of Texas
|
| Settlement date: | Oct. 5
|
| Stock symbol: | Nasdaq: MIRN
|
| Stock price: | $7.04 at close Oct. 2
|
| Market capitalization: | $117.43 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
